213 related articles for article (PubMed ID: 11137050)
1. Recent developments in amoebiasis:the Gal/GalNAc lectins of Entamoeba histolytica and Entamoeba dispar.
Pillai DR; Kain KC
Microbes Infect; 2000 Nov; 2(14):1775-83. PubMed ID: 11137050
[TBL] [Abstract][Full Text] [Related]
2. Prevention of intestinal amebiasis by vaccination with the Entamoeba histolytica Gal/GalNac lectin.
Houpt E; Barroso L; Lockhart L; Wright R; Cramer C; Lyerly D; Petri WA
Vaccine; 2004 Jan; 22(5-6):611-7. PubMed ID: 14741152
[TBL] [Abstract][Full Text] [Related]
3. Royal Society of Tropical Medicine and Hygiene Meeting at Manson House, London, 19 February 1998. Amoebic disease. Entamoeba histolytica and E. dispar: comparison of molecules considered important for host tissue destruction.
Tannich E
Trans R Soc Trop Med Hyg; 1998; 92(6):593-6. PubMed ID: 10326098
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Proteomics Reveals Metabolic Reprogramming in Host Cells Induced by Trophozoites and Intermediate Subunit of Gal/GalNAc Lectins from Entamoeba histolytica.
Zhao Y; Li X; Zhou R; Zhang L; Chen L; Tachibana H; Feng M; Cheng X
mSystems; 2022 Apr; 7(2):e0135321. PubMed ID: 35343800
[TBL] [Abstract][Full Text] [Related]
5. [Utility and limitations of laboratory diagnosis of amebiasis].
Merens A; Rapp C; Fabre R; Cavallo JD
Med Trop (Mars); 2005; 65(2):167-75. PubMed ID: 16038358
[TBL] [Abstract][Full Text] [Related]
6. Myosin II and the Gal-GalNAc lectin play a crucial role in tissue invasion by Entamoeba histolytica.
Coudrier E; Amblard F; Zimmer C; Roux P; Olivo-Marin JC; Rigothier MC; Guillén N
Cell Microbiol; 2005 Jan; 7(1):19-27. PubMed ID: 15617520
[TBL] [Abstract][Full Text] [Related]
7. [Differentiation of Entamoeba histolytica from Entamoeba dispar using Gal/GalNAc-lectin and polymerase chain reaction].
López OY; López MC; Corredor V; Echeverri MC; Pinilla AE
Rev Med Chil; 2012 Apr; 140(4):476-83. PubMed ID: 22854693
[TBL] [Abstract][Full Text] [Related]
8. Entamoeba histolytica: Overexpression of the gal/galnac lectin, ehcp2 and ehcp5 genes in an in vivo model of amebiasis.
Sánchez V; Serrano-Luna J; Ramírez-Moreno E; Tsutsumi V; Shibayama M
Parasitol Int; 2016 Dec; 65(6 Pt A):665-667. PubMed ID: 27616150
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the C-Terminal Fragment of Entamoeba histolytica Gal/GalNAc Lectin Intermediate Subunit as a Vaccine Candidate against Amebic Liver Abscess.
Min X; Feng M; Guan Y; Man S; Fu Y; Cheng X; Tachibana H
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004419. PubMed ID: 26824828
[TBL] [Abstract][Full Text] [Related]
10. The Gal/GalNac lectin as a possible acetylcholine receptor in
Pacheco-Sánchez M; Martínez-Hernández SL; Muñoz-Ortega MH; Reyes-Martínez JA; Ávila-Blanco ME; Ventura-Juárez J
Front Cell Infect Microbiol; 2023; 13():1110600. PubMed ID: 37260701
[No Abstract] [Full Text] [Related]
11. Entamoeba histolytica: from adherence to enteropathy.
Ravdin JI
J Infect Dis; 1989 Mar; 159(3):420-9. PubMed ID: 2536786
[TBL] [Abstract][Full Text] [Related]
12. Amoebiasis vaccine development: A snapshot on E. histolytica with emphasis on perspectives of Gal/GalNAc lectin.
Singh RS; Walia AK; Kanwar JR; Kennedy JF
Int J Biol Macromol; 2016 Oct; 91():258-68. PubMed ID: 27181579
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of surface glycoconjugates on Entamoeba histolytica and Entamoeba dispar.
Pacheco-Yépez J; Campos-Rodríguez R; Rojas-Hernández S; Serrano-Luna JJ; Rivera-Aguilar V; Villa-Treviño S; Martínez-Palomo A; Tsutsumi V; Shibayama M
Parasitol Int; 2009 Jun; 58(2):171-7. PubMed ID: 19269346
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo interaction of Entamoeba histolytica Gal/GalNAc lectin with various target cells: an immunocytochemical analysis.
Pacheco J; Shibayama M; Campos R; Beck DL; Houpt E; Petri WA; Tsutsumi V
Parasitol Int; 2004 Mar; 53(1):35-47. PubMed ID: 14984834
[TBL] [Abstract][Full Text] [Related]
15. Initiation of inflammation and cell death during liver abscess formation by Entamoeba histolytica depends on activity of the galactose/N-acetyl-D-galactosamine lectin.
Blazquez S; Rigothier MC; Huerre M; Guillén N
Int J Parasitol; 2007 Mar; 37(3-4):425-33. PubMed ID: 17188278
[TBL] [Abstract][Full Text] [Related]
16. Comparison of hemolytic activity of the intermediate subunit of Entamoeba histolytica and Entamoeba dispar lectins.
Kato K; Makiuchi T; Cheng X; Tachibana H
PLoS One; 2017; 12(7):e0181864. PubMed ID: 28750000
[TBL] [Abstract][Full Text] [Related]
17. Stable expression of Gal/GalNAc lectin of Entamoeba histolytica in transgenic chloroplasts and immunogenicity in mice towards vaccine development for amoebiasis.
Chebolu S; Daniell H
Plant Biotechnol J; 2007 Mar; 5(2):230-9. PubMed ID: 17309678
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional and secretory responses of Entamoeba histolytica to mucins, epithelial cells and bacteria.
Debnath A; Tashker JS; Sajid M; McKerrow JH
Int J Parasitol; 2007 Jul; 37(8-9):897-906. PubMed ID: 17362964
[TBL] [Abstract][Full Text] [Related]
19. The galactose-inhibitable surface lectin of Entamoeba histolytica, a possible candidate for a subunit vaccine to prevent amoebiasis.
Lotter H; Tannich E
Behring Inst Mitt; 1997 Mar; (99):112-6. PubMed ID: 9303210
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of pathogenic genes of Entamoeba histolytica vs E. dispar in a model of infection using human liver tissue explants.
Ximénez C; González E; Nieves M; Magaña U; Morán P; Gudiño-Zayas M; Partida O; Hernández E; Rojas-Velázquez L; García de León MC; Maldonado H
PLoS One; 2017; 12(8):e0181962. PubMed ID: 28771523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
